Clinical Endoscopic Submucosal Dissection of Trainees Tutored by Experts—ESGE Endorsed Courses and Live Endoscopic Events 2011–2015
Daniel Neureiter, Naohisa Yahagi, Tsuneo Oyama, Takashi Toyonaga, Tobias Kiesslich, Andrej Wagner, Franz Ludwig Dumoulin, Alexander Ziachehabi, Hans-Peter Allgaier, Michael Anzinger, Gerhard Kleber, Hans Seifert, Alberto Herreros de Tejada, Ingo Steinbrück, Barbara Tribl

TL;DR
Expert-led training in endoscopic submucosal dissection (ESD) for early gastrointestinal cancers in Europe achieved high success rates and low complications, even when performed by trainees.
Contribution
Demonstrates the effectiveness of expert-tutored ESD training in Europe for achieving curative outcomes and standardizing complex procedures.
Findings
Curative and en bloc resection rates were 88% and 95%, with no recurrence after R0 resections during a median 9.8-year follow-up.
Adverse events occurred in 9.3% of cases, with no emergency surgery or 30-day mortality.
Trainees correctly applied curative ESD indications in 94% of cases and achieved a 75% self-completion rate on smaller lesions.
Abstract
Background/Objectives: Endoscopic submucosal dissection (ESD) is a state-of-the-art en bloc resection for early gastro-intestinal cancers and precursors developed and validated in Japan. Western expertise with this complex technique remains limited. Tutored training might be optimal for patients and ESD learning. We established ESD tutoring courses led by experienced Japanese experts to provide (i) optimal long-term curative outcomes and low complication rates for patients and (ii) hands-on training on difficult lesions for European endoscopists under direct expert supervision. Methods: Prospective data from 2011 to 2015 (follow-up to 12/2024) were analyzed. A total of 118 neoplasms (50% HGIEN and cancer) in 101 patients (median age 68 [37–91] years; 38% with significant comorbidities) were treated with expert or tutored ESD. Japanese experts performed 28 ESDs, while 22 trained…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGastric Cancer Management and Outcomes · Esophageal Cancer Research and Treatment · Gastrointestinal Tumor Research and Treatment
